Validation of cardiovascular risk scores in people living with HIV in Colombia.

Authors

Andres Felipe Salazar-Urbano, Pablo Andres Lopez-Bernal, Mariana Sánchez-Martínez, Jesika Lorena Cruz-Muñoz, Karol Daniela Mosquera-Niño, Luis Gabriel Reyes-Hernández, Otto Alberto Sussmann-Peña

Published in

Enfermedades infecciosas y microbiologia clinica (English ed.). Pages 503231. Sep 05, 2026. Epub Sep 05, 2026.

Abstract

People living with HIV (PLWH) have a higher risk of cardiovascular disease compared with the general population. The usefulness of traditional cardiovascular risk scores in this population has not been fully established in Colombia.
To evaluate and compare the predictive performance of different cardiovascular risk scores for the prediction of major adverse cardiovascular events in a cohort of people living with HIV.
A retrospective cohort study was conducted in 911 PLWH attended at a specialized institution in Bogotá between 2003 and 2014, with a ten-year follow-up. Cardiovascular risk scores were calculated using the Framingham, Framingham ATP III, Framingham adjusted for Colombia, PROCAM, DAD, and ASCVD models. Discriminative performance was assessed using the area under the curve (AUC) analysis.
A low incidence of major adverse cardiovascular events (3.4%) was observed. All risk scores demonstrated apparently adequate discriminative capacity, with the ASCVD score showing the best performance (AUC 0.927; 95% CI: 0.87-0.98). A high correlation was observed among all evaluated risk scores (0.9).
All evaluated risk scores showed apparently adequate discriminative and calibration capacity in this cohort of Colombian PLWH, with the ASCVD score showing the highest AUC. However, the low number of events, the retrospective design, and the absence of external validation limit the strength of these findings, which should be considered preliminary evidence pending confirmation through prospective, multicenter studies.

PMID:
42701050
Bibliographic data and abstract were imported from PubMed on 06 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.